How nurse practitioner teams help patients with dementia and address racial and ethnic disparities
Official title: Social Networks in Nurse Practitioner Teams Caring for Patients with Dementia and Impact on Racial and Ethnic Disparities
Funded at Columbia University Health Sciences · NIH-11085081 · Data updated 2026-11-12
This study is looking at how nurse practitioner teams can work together to provide better care for people with Alzheimer's and related dementias, especially for those from different racial and ethnic backgrounds, to help improve their overall health and support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | May 15, 2024 |
| Project end | January 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $617,340 |
| NIH project number | 5R01AG085479-02 |
| Project ID | NIH-11085081 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults aged 65 and above who are living with Alzheimer's Disease or related dementias, especially those from racial and ethnic minority backgrounds.
✕Less likely to help
Patients who are younger than 65 or do not have Alzheimer's Disease or related dementias may not receive benefits from this research.
What this research studies
This research investigates the role of nurse practitioner (NP) teams in providing care for patients with Alzheimer's Disease and related dementias, particularly focusing on how these teams can reduce racial and ethnic disparities in care. The study will explore the social networks within NP teams, examining how team members communicate and support each other to improve patient outcomes. By utilizing a mixed-methods approach, the research aims to identify effective team configurations and practices that enhance the quality of care for persons living with dementia. The findings could inform better care models that leverage the strengths of NP teams in addressing the needs of diverse patient populations.
Why it matters
Potential benefit: If successful, this research could lead to improved care models that enhance the quality of life for patients with dementia, particularly among racial and ethnic minorities.
How similar studies have gone: While the focus on NP teams in dementia care is relatively novel, there is growing evidence that team-based care can improve health outcomes for patients with chronic conditions.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Poghosyan, Lusine — Columbia University Health Sciences
- Study coordinator: Poghosyan, Lusine
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Synthetic protein mimetics to treat Lewy Body Dementia
A new therapeutic approach using engineered protein-like molecules to block the harmful protein clumps that cause Lewy Body Dementia.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
New biomarkers to distinguish LATE from Alzheimer’s disease in dementia
A study to develop blood and CSF tests that can tell apart LATE from Alzheimer’s disease in people with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.